在急性髓性白血病中利用免疫反应
Carola Riva1, Chiara Vernarecci1, Paola Minetto2
1Clinic of Hematology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
Journal of clinical medicine
|September 28, 2023
概括
细胞疗法对急性髓性白血病 (AML) 是有前途的,特别是在复发/耐药患者中. 本综述涵盖了创新的基于细胞的治疗方法,包括CAR-T和CAR-NK疗法,提供了新的希望.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 传统化疗和向疗法对复发性/耐药性 (R/R) 急性髓性白血病 (AML) 的生存益处有限.
- 细胞疗法已经在其他血液性恶性瘤中取得了成功,目前已有批准的产品可供使用.
- 对于R/RAML的有效治疗方法存在重大未满足的需求,特别是在老年或不适合治疗的患者中.
研究的目的:
- 审查AML细胞疗法最近的临床研究.
- 探索各种细胞疗法方法,从既有方法到新型采用免疫疗法.
- 突出细胞疗法的潜力,作为一种替代Allogeneic造血干细胞移植的替代方案.
主要方法:
- 审查当前的临床研究和关于AML细胞治疗的文献.
- 讨论已建立的细胞疗法方法,包括输注捐赠淋巴细胞.
- 分析现代采用免疫疗法,如全活性NK细胞,CAR-T和CAR-NK细胞以及T/NK细胞参与平台 (BiTEs,DARTs,ANKETTM).
主要成果:
- 细胞疗法,包括工程T和NK细胞,正在积极研究R/RAML.
- 早期数据表明,AML的各种细胞疗法模式的潜在疗效和安全性.
- 目前没有细胞疗法产品被批准用于R/RAML,这表明有进一步发展的领域.
结论:
- 细胞疗法代表了R/RAML治疗的前沿,为无法接受干细胞移植的患者提供了潜在的替代方案.
- 对工程T细胞和NK细胞以及新的参与平台的持续研究对于推进AML治疗至关重要.
- 需要进行进一步的临床试验,以确定这些创新的细胞疗法在AML中的疗效和安全性.
相关概念视频
Cell-mediated Immune Responses
68.7K
Overview
68.7K
Cytotoxic T Cells-mediated Immune Response
956
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
956
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551


